SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (522)3/17/1999 1:53:00 AM
From: scaram(o)ucheRead Replies (1) of 4974
 
Good stuff!

I have one comment about the Duke work..... it's very convincing work, but it demonstrates only very weak activity for angio in inhibiting the proliferation of endothelial cells. That is, they convincingly describe the receptor, but.... who cares?

But, Gawwwwwwd, what a neat story..... tumors feeding on dying cells, a unique mechanism for growth.

But, now, returning to the real world of pharmaceuticals......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News